News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
MEDTOX Scientific Announces First Quarter Results
April 12, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ST. PAUL, Minn., April 12, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the first quarter ended March 31, 2012. Highlights from the quarter compared to the prior-year period include:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Drug pricing
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy
August 14, 2025
·
3 min read
·
Annalee Armstrong
Obesity
Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership
August 14, 2025
·
1 min read
·
Dan Samorodnitsky
Layoffs
Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis
August 14, 2025
·
2 min read
·
Tristan Manalac
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
August 14, 2025
·
1 min read
·
Lori Ellis
